Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perclose device successful in first human trial:

This article was originally published in Clinica

Executive Summary

Perclose claims that initial human clinical testing of its automated device for suturing blood vessels during conventional or minimally invasive coronary artery bypass surgery has shown promising results. The Menlo Park, California-based company said that by automating the delivery of 10 needles and sutures to the coronary artery and saphenous vein, its Heartflo system provided a precise, consistent and repeatable suture pattern. An automated suturing approach is expected to be particularly important during minimally invasive cardiac surgery where surgeons have to work through small incisions in the chest, often on a beating heart.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel